DUBLIN, April 23, 2018 /PRNewswire/ --
The "Next generation Sequencing Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
Next generation sequencing market is projected to expand at a CAGR of 20.21%, to grow from US$4.374 billion in 2017 to US$13.198 billion by 2023.
The global demand for next-generation sequencing (NGS) products and services is highly driven by an increase in the application of NGS, technological advancement in NGS technology, increase in genome mapping programs, and surge in collaborations and partnerships resulting in high investments in R&D in NGS technology.
The efficient replacement of traditional technologies (microarrays), cost efficiency, speed and accuracy of technology along with the rise in the application in drug discovery will aid to the global next-generation sequencing demand growth over next five years.
However, lack of skilled professionals, interpretation of complex data, and legal and ethical issues are expected to hinder the NGS market growth.
Major industry players profiled as part of the report are Roche Holding AG, Agilent Technologies, Thermo Fisher Scientific, Beijing Genomics Institute, GATC Biotech AG, and Pacific Biosciences of California, Inc. among others.
Key Topics Covered
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NEXT GENERATION SEQUENCING MARKET BY PRODUCTS AND SERVICES
5.1. Sequencing Systems
5.4. Sequencing Services and Analysis
6. NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY
6.1. Sequencing by Synthesis
6.2. ION Torrent Sequencing
6.3. Nanopore Sequencing
7. NEXT GENERATION SEQUENCING MARKET BY APPLICATION
7.1. Agriculture and Animal Research
7.2. Biomarker Discovery
7.3. Drug Discovery
7.5. Precision Medicine
8. NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY
8.1. North America
8.2. South America
8.4. Middle East and Africa
8.5. Asia Pacific
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. COMPANY PROFILES
10.1. Roche Holding AG
10.2. Agilent Technologies
10.3. Illumina, Inc.
10.4. Thermo Fisher Scientific
10.5. Macrogen, Inc.
10.6. Beijing Genomics Institute
10.9. GATC Biotech AG
10.10. Pacific Biosciences of California, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/97bb78/next_generation?w=5
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets